By improving the level of early diagnosis and treatment of Crohn disease in order to improve the curative effect and prognosis

doi:10.3877/cma.j.issn.2095-2015.2021.01.006

Abstract

Abstract:

The early diagnosis and treatment of Crohn disease is a complex and challenging clinical problem.Early diagnosis and treatment of Crohn disease is of great significance for improving therapeutic effect and prognosis, promoting disease remission, reducing complications, preventing recurrence and improving quality of life.Comprehensive judgment based on clinical manifestations, endoscopy, pathology, laboratory, imaging and other data is an important means of early diagnosis, and treatment in early stage to strive for mucosal healing is an important way to improve the efficacy and prognosis of Crohn disease.

Key words: Crohn disease, Diagnosis, Treatment

Wensong Ge. By improving the level of early diagnosis and treatment of Crohn disease in order to improve the curative effect and prognosis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(01): 28-30.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2021.01.006

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2021/V11/I01/28

References 12

1	Peyrin-Biroulet L, Loftus EV Jr, Colombel JF，et al.Early Crohn disease：a proposed definition for use in diseasemodification trials[J]．Gut，2010，59(2): 141-147.
2	Peyrin-Biroulet L, Billioud V, D′Haens G，et al.Development of the Paris definition of early Crohn′s disease for disease modification trials：results of an international expert opinionprocess[J]．Am J Gastroenterol，2012，107(12): 1770-1776.
3	Schoepfer AM, Dehlavi MA, Fournier N，et al.IBD Cohort Study Group.Diagnostic delay in Crohn′s disease is associated with a complicated disease course and increased operation rate[J]．Am J Gastroenterol，2013，108(11): 1744-1753.
4	Baert F, Moortgat L, van Assche G，et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn′s disease[J]. Gastroenterology，2010，138(2): 463-468.
5	Colombel JF, Rutgeerts PJ, Sandborn WJ，et al. Adalimumab induces deep remission in patients with Crohn′s disease[J]. Clin Gastroenterol Hepatol，2014，12(3): 414-422.e5.
6	Colombel JF, Rutgeerts P, Reinisch W，et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis[J]. Gastroenterology，2011，141(4): 1194-1201.
7	Darr U, Khan N. Treat to target in inflammatory bowel disease：an updated review of literature[J]. Curr Treat Options Gastroenterol，2017，15(1): 116-125.
8	Peyrin-Biroulet L, Reinisch W, Jean-Frederic Colombel et al.Clinical disease activity，C-reactive protein normalisation and mucosal healing in Crohn′s disease in the SONIC trial[J]．Gut，2014，63(1): 88-95.
9	Sandborn WJ, Panaccione R, Thakkar R，et al. Duration of Crohn′s disease affects mucosal healing in adalimumab-treated patients：results from EXTEND[J]. J Crohns Colitis Suppl，2010，4: S36-S37.
10	Engel T, Ungar B, Yung DE，et al.Vedolizumab in IBD-Lessons From Real-world Experience；A Systematic Review and Pooled Analysis[J]．J Crohn Colitis，2018，12: 245-257.
11	Henderson P, Anderson NH, Wilson DC.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease：a systematic review and meta-analysis[J]．Am J Gastroenterol，2014，109(5): 637-645.
12	Aomatsu T, Imaeda H, Matsumoto K，et al.Faecal chitinase 3-like-1：a novel biomarker of disease activity in paediatric inflammatory bowel disease[J]．Aliment Pharmacol Ther，2011，34(8): 941-948.

[1]	Hongbin Wang, Hongxia Zhang, Wen He, Lijuan Du, Linggang Cheng, Yukang Zhang, Meng Zhang. Ultrasound and contrast-enhanced ultrasound features of low-grade appendiceal mucinous tumor and appendiceal mucinous adenocarcinoma [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 865-871.
[2]	Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[3]	Huazhi Li, Guang Cao, Diangang Liu, Yajing Zhang. Clinical comparison of descending hepatectomy with different approaches for primary hepatocellular carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 52-55.
[4]	Hao Chen, Meng Wang. Advances in clinicopathological features and treatment options of sig-ring cell carcinoma of the stomach [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 108-111.
[5]	Qiusheng Wang. Diagnosis and treatment strategy for benign biliary diseases [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 779-782.
[6]	Yifan Li, Diwen Zhu, Weixin Ren, Yingjun Bao, Junpeng Gu, Haixiao Zhang, Gengfei Cao, Weizheng Ji. Role of serum GP73 level in the evaluation of TACE efficacy for primary liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 825-830.
[7]	Yuhan Yuan, Shengli Yang. Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 883-888.
[8]	Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[9]	Bin Shi, Yuan Si. Effect of Yiqiheluo formula combined with valsartan in the treatment of IgA nephropathy with deficiency of both qi and yin plus blood stasis syndrome [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 306-312.
[10]	Wenkai Guo, Pengcheng Ji, Jingru Bi, Yuansheng Xie. Ten treatment measures for IgA nephropathy [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 327-333.
[11]	Xuan Tie, Xiaole Su, Lihua Wang. Progress of research on the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 345-351.
[12]	Hao Li, Qishuai Chen, Fazhu Fei, Ningwei Zhang, Yuandong Li, Shuochen Wang, Bin Ren. Progress in noninvasive diagnosis of liver fibrosis in chronic liver disease [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 863-867.
[13]	Ruiyi Tan. Current advances and developments in diagnosis and treatment of small cell osteosarcoma [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 781-784.
[14]	Ziyang Wang, Hongbin Wang, Xiaojing Liu. Progress in research of serum markers for diagnosis of alpha-fetoprotein negative hepatocellular carcinoma [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 677-681.
[15]	Hui Chen, Zupeng Zou, Tiantian Zhou, Yidan Zhang, Haiping Zhang. Progress in research of dermoscopy in differential diagnosis of erythematous dermatosis on the scalp [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 692-698.

Please choose a citation manager

Content to export